Optical Spectroscopy during surgery on the median nerve

Optical Spectroscopy during surgery on the median nerve - Spectrometry Median Nerve

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36842

Enrollment

Registered

2013-01-10

Start date

2013-05-22

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse optical reflection spectrum (color) of median nerve

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Surgical release of carpal tunnel syndrome

Exclusion criteria

Exclusion criteria: Pre- or peroperative use of medication with phototoxic side effects: - Amiodaron (also Cordarone) - Chloorpromazine (also Largactil) - Hydrochloorthiazide - Nalidixinezuur (also Nevigramon, Neggram of Wintomylon) - Tetracycline (also Tetralysal, Panmycin, Brodspec, Terramycine of Tetracap) - Doxycycline (also Vibramycin) - Naproxen (also Naproxenum, Naproxennatrium, Aleve, Anaprox, Naprosyne, Femex, Naprocoat, Naprovite, Nycopren, Naprelan, Teva of Topgen) - Piroxicam - Thioridazine (also Mellaril, Novoridazine, Thioril) - Voriconazol (also VFEND) - Phenothiazines - Dacarbazine - Ketoprofen - Lomefloxacin (also maxaquin) or other fluoroquinolones

Design outcomes

Primary

Measure	Time frame
Accurate broadband (400 - 1830nm) diffuse reflectance spectra of human nerve tissue in vivo	—

Secondary

Measure	Time frame
Optimal probe positioning and comparison with camera images of tissue	—

Countries

Netherlands

Outcome results